Payam Peymani
Payam Peymani
Pharm.D, PhD, College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba
Verified email at umanitoba.ca - Homepage
Title
Cited by
Cited by
Year
Health in the Islamic Republic of Iran, challenges and progresses
KB Lankarani, SM Alavian, P Peymani
Medical journal of the Islamic Republic of Iran 27 (1), 42, 2013
1592013
Quantum dot: magic nanoparticle for imaging, detection and targeting
Y Ghasemi, P Peymani, S Afifi
Acta Biomed 80 (2), 156-165, 2009
1542009
Epidemiological characteristics of fatal traffic accidents in Fars province, Iran: a community-based survey
ST Heydari, A Hoseinzadeh, F Ghaffarpasand, A Hedjazi, M Zarenezhad, ...
Public health 127 (8), 704-709, 2013
732013
Fatal motorcycle accidents in Fars Province, Iran: a community-based survey
ST Heydari, NN Maharlouei, A Foroutan, Y Sarikhani, F Ghaffarpasand, ...
Chinese journal of traumatology 15 (4), 222-227, 2012
552012
Hepatitis B and C virus-induced hepatitis: Apoptosis, autophagy, and unfolded protein response
B Yeganeh, AR Moghadam, J Alizadeh, E Wiechec, SM Alavian, ...
World journal of gastroenterology 21 (47), 13225, 2015
522015
Epidemiological characteristics of fatal pedestrian accidents in Fars Province of Iran: a community-based survey
P Peymani, ST Heydari, A Hoseinzadeh, Y Sarikhani, G Moafian, ...
Chinese journal of traumatology 15 (5), 279-283, 2012
482012
Time analysis of fatal traffic accidents in Fars Province of Iran
ST Heydari, Y Sarikhani, G Moafian, MR Aghabeigi, M Mahmoodi, ...
Chinese journal of traumatology 16 (2), 84-88, 2013
422013
Evaluation of the sensitivity and reliability of primary rainbow trout hepatocyte vitellogenin expression as a screening assay for estrogen mimics: methodological issues
S Sabour, F Farzaneh, P Peymani
Aquatic toxicology (Amsterdam, Netherlands) 164, 175-176, 2015
402015
The effects of curcumin on weight loss among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials
M Akbari, KB Lankarani, R Tabrizi, M Ghayour-Mobarhan, P Peymani, ...
Frontiers in pharmacology 10, 649, 2019
392019
New use of an old drug: chloroquine reduces viral and ALT levels in HCV non-responders (a randomized, triple-blind, placebo-controlled pilot trial)
P Peymani, B Yeganeh, S Sabour, B Geramizadeh, MR Fattahi, ...
Canadian journal of physiology and pharmacology 94 (6), 613-619, 2016
342016
Common carotid intima-media thickness in patients with non-alcoholic fatty liver disease: a population-based case-control study
KB Lankarani, M Mahmoodi, M Lotfi, N Zamiri, ST Heydari, ...
The Korean Journal of Gastroenterology 62 (6), 344-351, 2013
332013
Adverse drug reactions reporting: pharmacists' knowledge, attitude and practice in Shiraz, Iran
S Afifi, N Maharloui, P Peymani, S Namazi, AG Gharaei, P Jahani, ...
International Journal of Risk & Safety in Medicine 26 (3), 139-145, 2014
282014
The effects of resveratrol supplementation on biomarkers of inflammation and oxidative stress among patients with metabolic syndrome and related disorders: a systematic review …
R Tabrizi, OR Tamtaji, KB Lankarani, N Mirhosseini, M Akbari, ...
Food & function 9 (12), 6116-6128, 2018
252018
Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients
P Peymani, T Dehesh, F Aligolighasemabadi, M Sadeghdoust, K Kotfis, ...
Translational medicine communications 6 (1), 1-14, 2021
192021
THE PREVALENCE OF HIGH BLOOD PRESSURE AND ITS RELATIONSHIP WITH ANTHROPOMETRIC INDICATORS, A POPULATION BASED STUDY IN FARS PROVINCE, IR IRAN
P Peymani, ST Heydari, SM Ahmadi, Y Sarikhani, H Joulaei, ...
INTERNATIONAL CARDIOVASCULAR RESEARCH JOURNAL 6 (219), 40-45, 2012
192012
Protective effects of pharmacological agents against aminoglycoside-induced nephrotoxicity: A systematic review
M Mahi-Birjand, S Yaghoubi, M Abdollahpour-Alitappeh, Z Keshtkaran, ...
Expert opinion on drug safety 19 (2), 167-186, 2020
172020
Knowledge, attitude and practice of general practitioners towards adverse drug reaction reporting in South of Iran, Shiraz (Pharmacoepidemiology report)
P Peymani, R Tabrizi, S Afifi, S Namazi, ST Heydari, MK Shirazi, ...
International Journal of Risk & Safety in Medicine 28 (1), 25-31, 2016
162016
Synthesis, Cytotoxicity, and QSAR Study of New Aza‐cyclopenta [b] fluorene‐1, 9‐dione Derivatives
R Miri, O Firuzi, P Peymani, M Zamani, AR Mehdipour, Z Heydari, ...
Chemical biology & drug design 79 (1), 68-75, 2012
162012
The effects of probiotic supplementation on clinical symptom, weight loss, glycemic control, lipid and hormonal profiles, biomarkers of inflammation, and oxidative stress in …
R Tabrizi, V Ostadmohammadi, M Akbari, KB Lankarani, S Vakili, ...
Probiotics and antimicrobial proteins, 1-14, 2019
142019
The effects of statin use on inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled …
R Tabrizi, OR Tamtaji, N Mirhosseini, KB Lankarani, M Akbari, ...
Pharmacological research 141, 85-103, 2019
132019
The system can't perform the operation now. Try again later.
Articles 1–20